Statin Use in Elderly Linked to Decrease in Risk of Death, Cardiovascular Mortality

July 07, 2020

New research is detailing the impact of statin use for primary prevention in elderly patients free from atherosclerotic cardiovascular disease.

Onset Timing, Severity of Menopausal Symptoms Help Predict Increased CVD Risk

July 07, 2020

A pooled analysis of 6 studies indicates both timing and increased severity of vasomotor menopausal symptoms could signal increased risk of cardiovascular disease events.

Black Patients at Greater Risk of MACE Following PCI

July 06, 2020

An analysis of 10 randomized clinical trials is shedding new light on the risk of MACE seen by Black patients following PCI versus risk among white counterparts.

Tirofiban Bests Cangrelor for Inhibiting Platelet Aggregation in FABOLUS-FASTER Study

June 30, 2020

Results of the FABOLUS-FASTER trial indicate tirofiban may be more effective than cangrelor in reducing risk of acute ischemic complications when used for bridging platelet inhibition in heart attack patients undergoing percutaneous coronary intervention.

Image IQ: 13-Year-Old Complains of Abdominal Pain, Red Dots, and Overheating

June 30, 2020

How good are your diagnostic skills?  Test them here with this month's Visual Dx quiz!

Increased Risk of Ischemic Heart Disease Associated With Pre-Term Deliveries

June 29, 2020

New research from an analysis of the Swedish Medical Birth Registry suggests women experience preterm delivery were at an increased risk of developing ischemic heart disease later in life.

Rivaroxaban Post-Discharge Reduces Thromboembolic Events in Acutely Ill Patients

June 25, 2020

Results of an exploratory analysis of the phase 3 MARINER study indicates post-discharge prophylaxis with rivaroxaban (Xarelto) could reduce the risk of both fatal and major thromboembolic events in medically ill patients.

ADA 2020: Decreasing Risk of Heart Failure Hospitalization With Empagliflozin

June 23, 2020

Findings of a recent study suggest empagliflozin is associated with a decreased risk of hospitalization for heart failure and a similar risk of myocardial infarction or stroke in routine clinical care.

For Diabetics, Heart Failure Associated With Worst Prognosis Among CVDs, CKD

June 23, 2020

New research suggests development of heart failure is associated with the greatest risk of death among type 2 diabetics with cardiovascular conditions.

AHA Awards Nonprofit Grants to Address Food and Healthcare Shortages Due to COVID-19

June 17, 2020

Twenty two nonprofit organizations have been awarded COVID-19 Rapid Response Grants as part of the American Heart Association’s Voices for Healthy Kids initiative.The grants range from $20,000 to $50,000 and will support work focused on improving access to healthy food, increasing access to health care and addressing income needs during and beyond the pandemic.

Diabetes Trial Shows Prevention Benefits Two Decades Later

June 16, 2020

New data released today from the Diabetes Prevention Program Outcomes Study (DPPOS) shows that in over 2000 patients followed for an average of 22 years, lifestyle programs and treatment with metformin continues to prevent the development of type 2 diabetes (T2D) in at risk populations.

Type 1 Diabetes Triggered First Two Years of Life, Research Says

June 15, 2020

New data from the Environmental Determinants of Diabetes in the Young (TEDDY) study illuminate the environmental triggers that are thought to cause the autoimmune response leading to type 1 diabetes(T1D) and celiac disease. The research, presented in a symposium at the American Diabetes Association meeting.shows that the destruction of the beta cells begins in the first two years of life.

Late Night Meals Bad for Blood Sugar Control and Weight Loss

June 12, 2020

A study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism has found that eating a late may be a contributing factor to weight gain and hyperglycemia -- factors that may also exaccerbate heart disease.

Women, Minorities and Older Adults Still Underrepresented in Clinical Trials: Conversation with Erin Michos MD

June 11, 2020

The outcomes of clinical trials are often affected by the diversity of the patient population studied.  Things like race and gender can make a real difference in the way drugs work– and yet women, minorities and older adults continue to be underrepresented in pivotal trials for new medications .  Two recent studies demonstrate that fact over the last several decades.  And although the proportion of these populations enrolled in clinical trials has increased, it is still well out of step with the number of patients affected by the diseases in question. Sr. Editor Gretchen Cuda Kroen spoke with Dr. Erin Michos,  co-author on those studies about the origins of the disparity, and what what we can do about it.